Catecholamines and Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury

Area of Science:

• Neuroscience
• Endocrinology
• Critical Care Medicine

Background:

• Paroxysmal sympathetic hyperactivity (PSH) is a recognized complication in intensive care unit patients following severe traumatic brain injury (TBI).
• The precise hormonal mechanisms, including the roles of catecholamines and the adrenocortical and thyroid axes, in PSH remain incompletely understood.
• Understanding these hormonal influences is crucial for managing PSH and improving outcomes for TBI survivors.

Purpose of the Study:

• To prospectively investigate and quantify the involvement of catecholamines and adrenocortical/thyroid hormones in the development and manifestation of PSH after severe TBI.
• To correlate hormonal fluctuations with PSH episodes and identify potential triggers.

Main Methods:

• Prospective data collection from 80 consecutive patients admitted to the ICU after severe TBI.
• Sequential measurement of catecholamine and hormonal levels at 4-hour intervals, and during/between PSH episodes.
• Clinical assessment for the presence and characteristics of PSH.

Main Results:

• Eighteen patients (22.5%) developed clinical signs of PSH.
• Significant increases (200-300%) in catecholamines and, to a lesser extent, adrenocortical hormones were observed during PSH paroxysms.
• The majority of PSH episodes (72%) were associated with identifiable triggering events.
• These hormonal changes were specific to patients experiencing PSH and not seen in controls.

Conclusions:

• PSH in severe TBI is associated with marked elevations in catecholamines and adrenocortical hormones.
• These hormonal surges provide a physiological basis for the adverse consequences of PSH in TBI survivors.
• Further research into modulating these hormonal responses may offer therapeutic avenues for PSH management.